182 related articles for article (PubMed ID: 32934746)
1. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
[TBL] [Abstract][Full Text] [Related]
2. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
[TBL] [Abstract][Full Text] [Related]
3. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
[TBL] [Abstract][Full Text] [Related]
4. Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.
Al-Azayzih A; Missaoui WN; Cummings BS; Somanath PR
Nanomedicine; 2016 Jul; 12(5):1231-1239. PubMed ID: 26949163
[TBL] [Abstract][Full Text] [Related]
5. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
[TBL] [Abstract][Full Text] [Related]
6. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
Wang Y; Gratzke C; Tamalunas A; Wiemer N; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Liu C; Stief CG; Hennenberg M
PLoS One; 2016; 11(4):e0153312. PubMed ID: 27071060
[TBL] [Abstract][Full Text] [Related]
7. PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.
Verma A; Artham S; Alwhaibi A; Adil MS; Cummings BS; Somanath PR
Biochem Pharmacol; 2020 Jul; 177():113943. PubMed ID: 32240651
[TBL] [Abstract][Full Text] [Related]
8. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
9. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
10. The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes.
Singhal R; Kandel ES
Oncotarget; 2012 Jul; 3(7):700-8. PubMed ID: 22869096
[TBL] [Abstract][Full Text] [Related]
11. Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in mice.
Kedar E; Braun E; Rutkowski Y; Emanuel N; Barenholz Y
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):115-24. PubMed ID: 7804526
[TBL] [Abstract][Full Text] [Related]
12. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
[TBL] [Abstract][Full Text] [Related]
13. A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.
Kalwat MA; Yoder SM; Wang Z; Thurmond DC
Biochem Pharmacol; 2013 Mar; 85(6):808-16. PubMed ID: 23246867
[TBL] [Abstract][Full Text] [Related]
14. Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.
Tunduguru R; Chiu TT; Ramalingam L; Elmendorf JS; Klip A; Thurmond DC
Biochem Pharmacol; 2014 Nov; 92(2):380-8. PubMed ID: 25199455
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts.
Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB
Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018
[TBL] [Abstract][Full Text] [Related]
16. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
17. Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes.
Kedar E; Rutkowski Y; Braun E; Emanuel N; Barenholz Y
J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):47-59. PubMed ID: 8081559
[TBL] [Abstract][Full Text] [Related]
18. Secretory phospholipase A
Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the use of sPLA
Pourhassan H; Clergeaud G; Hansen AE; Østrem RG; Fliedner FP; Melander F; Nielsen OL; O'Sullivan CK; Kjær A; Andresen TL
J Control Release; 2017 Sep; 261():163-173. PubMed ID: 28662900
[TBL] [Abstract][Full Text] [Related]
20. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling.
Li Z; Wang Q; Peng S; Yao K; Chen J; Tao Y; Gao Z; Wang F; Li H; Cai W; Lai Y; Li K; Chen X; Huang H
Clin Transl Med; 2020 Oct; 10(6):e191. PubMed ID: 33135357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
